Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic SyndromeGarrett W. Rhyasen, Daniel T. Starczynowski, Mark Wunderlich et al.|Cancer Cell|2013Cited by 203
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Javed Khan, Jun S. Wei et al.|Oncotarget|2015Cited by 70